⌘K

Home/Filings/4/0001104659-25-007565

4//SEC Filing

Kelly Steven 4

Accession 0001104659-25-007565

CIK 0001485003other

View on SEC.gov Company Profile

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 4:01 PM ET

Size

5.7 KB

Accession

0001104659-25-007565

Insider Transaction Report

Form 4

Period: 2025-01-28

Carisma Therapeutics Inc.CARM

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2025-01-28+500,000→ 500,000 total
Exercise: $0.50Exp: 2035-01-28→ Common Stock (500,000 underlying)

Footnotes (1)

[F1]The shares underlying this option vest over four years in equal monthly installments, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.

Documents

1 file

4
tm254883-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Carisma Therapeutics Inc.

CIK 0001485003

Entity typeother

Related Parties

1

filerCIK 0001339478

Filing Metadata

Form type: 4
Filed: Jan 29, 7:00 PM ET
Accepted: Jan 30, 4:01 PM ET
Size: 5.7 KB

View on SEC.gov